Detailed Information on Publication Record
2021
Composites of yeast glucan particles and curcumin lead to improvement of dextran sulfate sodium-induced acute bowel inflammation in rats
ROTREKL, Dominik, P. SALAMUNOVA, Lenka PARÁKOVÁ, Ondrej BAĎO, I. SALON et. al.Basic information
Original name
Composites of yeast glucan particles and curcumin lead to improvement of dextran sulfate sodium-induced acute bowel inflammation in rats
Authors
ROTREKL, Dominik (203 Czech Republic, guarantor, belonging to the institution), P. SALAMUNOVA, Lenka PARÁKOVÁ (203 Czech Republic, belonging to the institution), Ondrej BAĎO (703 Slovakia, belonging to the institution), I. SALON, F. STEPANEK, J. HANUS and J. HOSEK
Edition
Carbohydrate Polymers, Oxford, ELSEVIER SCI LTD, 2021, 0144-8617
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 10.723
RIV identification code
RIV/00216224:14160/21:00121162
Organization unit
Faculty of Pharmacy
UT WoS
000596264200008
Keywords in English
Colitis targeting; Curcumin; beta-Glucan; Yeast glucan particles; Inflammation
Tags
Tags
International impact, Reviewed
Změněno: 22/2/2021 13:01, PharmDr. Jitka Michlíčková
Abstract
V originále
The goal of this work was to assess the usability of yeast glucan particles (GPs) as carriers for curcumin and determine the beneficial effect of a pharmacological composite of curcumin in GPs on dextran sulfate sodium induced colitis in rats. The assessment of the anti-inflammatory effect of particular substances was evaluated on the basis of the calculated disease activity index and by assessment of cytokines and enzymes from the gut tissue - tumor necrosis factor alpha (TNF-alpha), transforming growth factor beta 1, interleukin (IL)-1 beta, IL-6, IL-10, IL-17, catalase, superoxide dismutase 2, myeloperoxidase (MPO), and matrix metalloproteinase 9. Composites of GPs with incorporated curcumin showed promising results with the capability to lower symptoms of colitis and significantly decrease the production of pro-inflammatory cytokines TNF-alpha, IL-1 beta, IL-6, and the activity of MPO, as well. The anti-inflammatory effect of the composites was greater than those of pure GPs or curcumin.